FTC chief predicts ban on pay-for-delay deals will pass this year

03/19/2010 | Wall Street Journal, The

Federal Trade Commission Chairman Jon Leibowitz said he thinks a proposal to prohibit pay-for-delay deals between brand-name and generic-drug companies will pass this year even if the measure gets dropped from the health reform bill. Leibowitz said bipartisan support is building for the proposal, which would restrict patent settlements that prevent the early launch of generic medicines.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA